Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

SELL
$49.1 - $62.37 $645,910 - $820,477
-13,155 Reduced 53.18%
11,583 $575,000
Q2 2023

Aug 10, 2023

SELL
$52.61 - $59.54 $76,600 - $86,690
-1,456 Reduced 5.56%
24,738 $1.47 Million
Q1 2023

May 12, 2023

BUY
$51.83 - $79.63 $626,158 - $962,010
12,081 Added 85.6%
26,194 $1.48 Million
Q4 2022

Feb 09, 2023

SELL
$58.4 - $75.53 $707,340 - $914,819
-12,112 Reduced 46.18%
14,113 $1.05 Million
Q3 2022

Nov 14, 2022

SELL
$55.32 - $67.54 $368,763 - $450,221
-6,666 Reduced 20.27%
26,225 $1.56 Million
Q2 2022

Aug 04, 2022

BUY
$53.08 - $81.37 $29,565 - $45,323
557 Added 1.72%
32,891 $1.85 Million
Q1 2022

May 13, 2022

SELL
$63.68 - $75.54 $247,078 - $293,095
-3,880 Reduced 10.71%
32,334 $2.39 Million
Q4 2021

Feb 10, 2022

BUY
$62.62 - $79.92 $985,012 - $1.26 Million
15,730 Added 76.79%
36,214 $2.62 Million
Q3 2021

Nov 12, 2021

BUY
$76.41 - $84.06 $1.57 Million - $1.72 Million
20,484 New
20,484 $1.57 Million
Q2 2021

Aug 10, 2021

SELL
$61.85 - $77.53 $1.23 Million - $1.54 Million
-19,827 Closed
0 $0
Q1 2021

May 13, 2021

SELL
$60.05 - $67.74 $313,881 - $354,076
-5,227 Reduced 20.86%
19,827 $1.22 Million
Q4 2020

Feb 10, 2021

SELL
$48.89 - $65.87 $992,907 - $1.34 Million
-20,309 Reduced 44.77%
25,054 $1.63 Million
Q3 2020

Nov 12, 2020

SELL
$45.26 - $57.82 $127,587 - $162,994
-2,819 Reduced 5.85%
45,363 $2.25 Million
Q2 2020

Aug 13, 2020

SELL
$39.81 - $55.61 $1.54 Million - $2.16 Million
-38,775 Reduced 44.59%
48,182 $2.3 Million
Q1 2020

May 14, 2020

BUY
$35.06 - $59.45 $1.85 Million - $3.14 Million
52,775 Added 154.39%
86,957 $3.7 Million
Q4 2019

Feb 10, 2020

BUY
$49.45 - $59.5 $1.69 Million - $2.03 Million
34,182 New
34,182 $2.01 Million

Others Institutions Holding GMED

About GLOBUS MEDICAL INC


  • Ticker GMED
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 77,037,200
  • Market Cap $7.12B
  • Description
  • Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devi...
More about GMED
Track This Portfolio

Track Aviva PLC Portfolio

Follow Aviva PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aviva PLC, based on Form 13F filings with the SEC.

News

Stay updated on Aviva PLC with notifications on news.